Ohrbach R (Editor) 2016. Diagnostic Criteria for Temporomandibular Disorders: Assessment Instruments (German). [Diagnostische Kriterien für Craniomandibuläre Dysfunktion: Untersuchungsbögen] German translation by Asendorf A, Eberhard L, and Schierz SD (2019). 2019
Sharma A Graham P Stafford. Periodontal Pathogen Sialometabolic Activity in Periodontitis. 2019
Lakshminrusimha S, Kinsella JP, Krishnan US, Van Meurs K, Edwards EM, Bhatt DR, Chandrasekharan PK, Oei JL, Manja V, Ramanathan R, Abman SH. Just Say No to iNO in Preterms-Really? J Pediatr. 2019
Kumamaru, K, Angel, ER, Sommer, KN, Iyer VS, Wilson MF, Agrawal, N, Bhradwaj, A, Kattel, SB, Kondziela, S, Pogorzelski, K, Ramanan, T, Sawant, A, Manion, C, Suplicki, MM, Waheed, S, Fujimoto, S, Sharma U, Ionita CN, Rybicki, F. Comprehensive analysis of inter- and intra-operator variability in measurement of CT-derived fractional flow reserve based on structural and fluid analysis.. Cardiothoracic Imaging. 2019
Bansal N, Adams MJ, Ganatra S, Colan SD, Aggarwal S, Steiner R, Amdani S, Lipshultz ER, Lipshultz SE. Strategies to prevent anthracycline-induced cardiotoxicity in cancer survivors. Cardio-Oncology. 2019; 5
Kopp LM, Womer RB, Schwartz CL, Ebb DH, Franco VI, Hall D, Barkauskas DA, Krailo MD, Grier HE, Meyers PA, Wexler LH, Marina NM, Janeway KA, Gorlick R, Bernstein ML, Lipshultz SE, for the Children‘s Oncology Group. Effects of dexrazoxane on doxorubicin-related cardiotoxicity and second malignant neoplasms in children with osteosarcoma: a report from the Children’s Oncology Group. Cardio-Oncology. 2019; 5
Home-based CBT for UCPPS: Optimizing Treatment Selection, Mechanisms of Action, and Outcomes R01. Tova Ablove (Co-Investigator), Teresa Danforth (Co-Investigator), Alison Vargovich (Co-Investigator). National Institutes of Health – NIDDK. 11/1/2020-10/1/2025.
Suramin for Radiation-Induced Oral Mucositis. Keith Kirkwood (Co-Principal Investigator). national Institutes of Health. $207,526. 9/1/2020-8/1/2022.
Bioinformatic Approaches for Understanding Macrophage Plasticity and Microbiome in Oral Diseases. Keith Kirkwood (Principal Investigator). national Institutes of Health. $94,393. 4/1/2020-3/1/2021.
Keith Kirkwood (Co-Investigator). national Institutes of Health. $275,000. 4/1/2020-3/1/2022.
Mechanisms of Heat Sensing by Nociceptive Vanilloid Receptors. Feng Qin (Principal Investigator). NIH. $2,684,432. 4/1/2020-3/1/2025.
Immunologic and clinical studies on perinatal hepatitis C viral infection. Karl O. Yu (Principal Investigator). Wildermuth Foundation. $35,000. 4/1/2020-3/1/2021.
Effects of Chest Compression in a Neonatal Model of Asphyxia Induced Bradycardia. Praveen Chandrasekharan (Principal Investigator). Neonatal Resuscitation Program. $50,000. 1/1/2020-12/1/2022.
Effects of infant egg consumption on child health and cognition development. Heather Lehman (Co-Investigator), Xiaozhong Wen (Principal Investigator). Egg Nutrition Center. $199,806. 12/1/2019-12/1/2021.
A role for immune cell plasticity in commensal survival and escalation of inflammation. Jason Kay (Principal Investigator), Ashu Sharma (Co-Investigator), Michelle Visser (Co-Investigator). NIH/NIDCR. $1,952,242. 12/1/2019-11/1/2024.
Mobilization of Hematopoietic Progenitors with a Novel Agent. Thomas Cimato (Principal Investigator). Bristol Myers Squibb. 11/1/2019-11/1/2020.
Expansion of addictions treatment and technical advisement across New York state. Joshua Lynch (Principal Investigator). New York State DOH. $55,050. 10/1/2019-8/1/2020.
First Responders - Comprehensive Addiction and Recovery Act (FR-CARA). Brian Clemency (Co-Investigator), Joshua Lynch (Co-Investigator). Substance Abuse and Mental Health Administration. $45,000. 10/1/2019-9/1/2020.
Determining the value of PBP 7/8 as an antimicrobial target for XDR-A. baumannii. Thomas Russo (Principal Investigator). Veterans Administration. $699,244. 10/1/2019-9/1/2023.
Mechanisms of Gene Regulatory Network Evolution. Marc Halfon (Principal Investigator). NSF. $1,106,456. 9/1/2019-8/1/2023.
A 3D-printed micro-scaffold for MS Imaging and Spatially Resolved Determination of Mab and Receptors in Tissues. Jun Qu (Principal Investigator). Center for Protein Therapeutics. 9/1/2019-8/1/2020.